Consequences of Undiagnosed and Untreated Pain

Published Online: Thursday, October 20, 2011
Follow Pharmacy_Times:
Watch as Michael R. Clark, MD, MPH, MBA, associate professor and director of the Chronic Pain Treatment Programs and department of Psychiatry and Behavioral Sciences at Johns Hopkins Medical Institutions, talks about the consequences of pain going undiagnosed or untreated—particularly in terms of the impact on quality of life, and the importance of engaging patients early.

Related Articles
Sometimes, the pharmacist just can’t leave the counter. At certain locations, that dedication persists even after death, leading to tales of spectral pharmacists causing mischief and strange events at their former pharmacies.
B. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association (NCPA), discusses increasing generic drug prices and the problems they create for independent community pharmacists.
Latest Issues
$auto_registration$